美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70771-1752-1	70771-1752	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Lifesciences Limited	MIRABEGRON	25 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-1)
70771-1752-3	70771-1752	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Lifesciences Limited	MIRABEGRON	25 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-3)
70771-1752-9	70771-1752	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Lifesciences Limited	MIRABEGRON	25 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1752-9)
70771-1753-1	70771-1753	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Lifesciences Limited	MIRABEGRON	50 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-1)
70771-1753-3	70771-1753	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Lifesciences Limited	MIRABEGRON	50 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-3)
70771-1753-9	70771-1753	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Lifesciences Limited	MIRABEGRON	50 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-9)
70710-1160-1	70710-1160	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Pharmaceuticals (USA) Inc.	MIRABEGRON	50 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-1)
70710-1160-3	70710-1160	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Pharmaceuticals (USA) Inc.	MIRABEGRON	50 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-3)
70710-1160-9	70710-1160	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Pharmaceuticals (USA) Inc.	MIRABEGRON	50 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-9)
70710-1159-1	70710-1159	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Pharmaceuticals (USA) Inc.	MIRABEGRON	25 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-1)
70710-1159-3	70710-1159	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Pharmaceuticals (USA) Inc.	MIRABEGRON	25 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-3)
70710-1159-9	70710-1159	HUMAN PRESCRIPTION DRUG	Mirabegron	Mirabegron	TABLET, EXTENDED RELEASE	ORAL	20240123	N/A	ANDA	ANDA209488	Zydus Pharmaceuticals (USA) Inc.	MIRABEGRON	25 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-9)